Foster & Motley Inc. Cuts Stock Position in Leidos Holdings, Inc. (NYSE:LDOS)

Foster & Motley Inc. trimmed its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 15.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,438 shares of the aerospace company’s stock after selling 1,571 shares during the quarter. Foster & Motley Inc.’s holdings in Leidos were worth $1,216,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of LDOS. FMR LLC boosted its stake in Leidos by 27.8% during the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock worth $392,133,000 after buying an additional 522,764 shares during the period. JPMorgan Chase & Co. boosted its stake in Leidos by 13.1% during the third quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock worth $571,216,000 after buying an additional 405,256 shares during the period. International Assets Investment Management LLC boosted its stake in Leidos by 24,194.3% during the third quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock worth $61,459,000 after buying an additional 375,495 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Leidos by 51.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after buying an additional 283,558 shares during the period. Finally, Barclays PLC boosted its stake in Leidos by 53.1% during the third quarter. Barclays PLC now owns 576,022 shares of the aerospace company’s stock worth $93,891,000 after buying an additional 199,686 shares during the period. 76.12% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the transaction, the director now directly owns 20,001 shares in the company, valued at approximately $3,899,594.97. The trade was a 12.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Noel B. Geer purchased 2,000 shares of the company’s stock in a transaction dated Wednesday, November 20th. The shares were acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the purchase, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $322,260. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. 0.96% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Barclays lifted their price objective on shares of Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. The Goldman Sachs Group downgraded Leidos from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $228.00 to $153.00 in a research report on Thursday, December 12th. Royal Bank of Canada lifted their target price on Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. UBS Group initiated coverage on Leidos in a research report on Monday, December 2nd. They set a “neutral” rating and a $182.00 target price for the company. Finally, Robert W. Baird lifted their target price on Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Leidos currently has a consensus rating of “Moderate Buy” and an average price target of $179.07.

Leidos Stock Performance

LDOS stock opened at $142.25 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The business has a 50-day moving average price of $152.96 and a 200 day moving average price of $158.20. The company has a market capitalization of $18.98 billion, a P/E ratio of 16.20, a PEG ratio of 1.06 and a beta of 0.66. Leidos Holdings, Inc. has a 1-year low of $108.97 and a 1-year high of $202.90.

Leidos (NYSE:LDOS) last announced its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm’s revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the company posted $2.03 earnings per share. As a group, equities research analysts forecast that Leidos Holdings, Inc. will post 10.03 EPS for the current fiscal year.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.